Descriptor English: | Idarubicin | ||||||
Descriptor Spanish: |
Idarrubicina
| ||||||
Descriptor Portuguese: | Idarubicina | ||||||
Descriptor French: | Idarubicine | ||||||
Entry term(s): |
4 Demethoxydaunorubicin 4 Desmethoxydaunorubicin 4-Demethoxydaunorubicin 4-Desmethoxydaunorubicin Hydrochloride, Idarubicin IMI 30 IMI-30 IMI30 Idarubicin Hydrochloride NSC 256439 NSC-256439 NSC256439 |
||||||
Tree number(s): |
D02.455.426.559.847.562.050.200.300 D04.615.562.050.200.300 D09.408.051.059.200.300 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015255 | ||||||
Scope note: | An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antibiotics, Antineoplastic Topoisomerase II Inhibitors |
||||||
Registry Number: | ZRP63D75JW | ||||||
CAS Type 1 Name: | 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)- | ||||||
Previous Indexing: |
Antibiotics, Antineoplastic (1967-1988) Daunorubicin/analogs & derivatives (1975-1988) |
||||||
Public MeSH Note: | 89 |
||||||
History Note: | 89 |
||||||
DeCS ID: | 23687 | ||||||
Unique ID: | D015255 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1989/01/01 | ||||||
Date of Entry: | 1988/05/17 | ||||||
Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Idarubicin
- Preferred
IMI-30
- Narrower
NSC-256439
- Narrower
Idarubicin Hydrochloride
- Narrower
Concept UI |
M0023493 |
Scope note | An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA. |
Preferred term | Idarubicin |
Entry term(s) |
4 Demethoxydaunorubicin 4 Desmethoxydaunorubicin 4-Demethoxydaunorubicin 4-Desmethoxydaunorubicin |
Concept UI |
M0023494 |
Preferred term | IMI-30 |
Entry term(s) |
IMI 30 IMI30 |
Concept UI |
M0350672 |
Preferred term | NSC-256439 |
Entry term(s) |
NSC 256439 NSC256439 |
Concept UI |
M0023495 |
Preferred term | Idarubicin Hydrochloride |
Entry term(s) |
Hydrochloride, Idarubicin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey